Skip to content
logo
  • Home
  • About
    OverviewMeet the TeamPrimeVigilance
  • CRO
    OverviewOrphan Drug DevelopmentTherapeutic ExpertiseClinical Expertise: Phase I–IVSite Support ServicesCOVID-19CRO Publications and Resources
  • Investors
    Investor RelationsReports and PresentationsShareholder Communications
  • News and Events
    OverviewRegulatory News
  • Careers
  • Contact
  • Legal Information
  • Privacy & Cookie Policies
  • Sitemap

News and Events

Learn more about current happenings at Ergomed.

Latest News

1 Feb 2017 Ergomed notes co-development partner Aeterna Zentaris Completes Zoptrex™ Pivotal Phase [...]
17 Jan 2017 Ergomed to report very strong 2016 revenue growth and order [...]
20 Dec 2016 Proposed Board changes
30 Nov 2016 Award of options by Chief Executive Officer over personally owned [...]
29 Nov 2016 Ergomed strengthens PrimeVigilance with acquisition of European pharmacovigilance and regulatory [...]
16 Nov 2016 Ergomed’s co-development partner Modus Therapeutics announces that the Independent Data [...]
« 1 2 … 18 19 20 … 28 29 »

Previous Events

17 Nov 2020 Ergomed presenting at Jefferies Virtual London 2020 Healthcare Conference

United Kingdom

1 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7HJ

Please send general enquiries to: info@ergomedplc.com

Quick Links

  • CRO Publications and Resources
  • Investor Relations
  • News and Events
  • About Us
  • Careers
  • PrimeVigilance
  • Contact Us
logo
© Ergomed Plc 2017 - 2021
  • Anti-Slavery and Human Trafficking Statement
  • Legal Information
  • Privacy & Cookie Policies
  • Sitemap